PMC:7261349 / 0-179
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 39-46 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 39-46 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 163-170 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 163-170 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 63-71 | Species | denotes | patients | Tax:9606 |
| 4 | 39-46 | Chemical | denotes | heparin | MESH:D006493 |
| 5 | 77-85 | Disease | denotes | Covid-19 | MESH:C000657245 |
| 36 | 163-170 | Chemical | denotes | heparin | MESH:D006493 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 39-46 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
| T2 | 163-170 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 39-46 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T2 | 163-170 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-85 | Sentence | denotes | The association between treatment with heparin and survival in patients with Covid-19 |
| T2 | 87-95 | Sentence | denotes | Abstract |